Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Metastatic Castration-Resistant Prostate Cancer (mCRPC) × sipuleucel-T × 1 year × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2 Metastatic Castration-resistant Prostate Cancer 1

Interventions

sipuleucel-T 2 enzalutamide 2 gallium 68 PSMA-11 1 Vancomycin 1 Metronidazole 1 Docetaxel 1 Ciprofloxacin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05806814 2026-03-05

OU-SCC-EXCITE

University of Oklahoma

Phase 1 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06134232 2025-08-27

ProvONE

Dendreon

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡